Medrx Co.,Ltd. (4586.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

Market Cap

JPY 3.74B

MomentumView details →

1D Return

−3.33%

YTD Return

−46.30%

RSI (14)

34.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

Market Cap

JPY 3.74B

RSI (14)

34.5

MomentumView details →

1D Return

−3.33%

YTD Return

−46.30%

ProfitabilityView details →

Gross Margin

99.13%

Net Margin

−732.03%

EBITDA Margin

−724.32%

ROE (TTM)

−45.75%

ROA (TTM)

−43.44%

Asset Turnover

0.06x

GrowthView details →

Revenue YoY

−50.19%

EPS YoY

+0.30%

FCF YoY

—

Revenue CAGR 3Y

+29.46%

EPS CAGR 3Y

+6.03%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

23.62x

Quick Ratio

23.40x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

131.00M

Net Income (TTM)

−746.00M

Op. CF (TTM)

—

Next earningsNov 6, 2026 →

Latest newsMore news →

Medrx announced that its lidocaine tape formulation's US sales contract is expected in August, and launch in the fourth quarter.51d ago

MedRx Co. announced that the expected sales volume of its lidocaine tape product Bondlido for the next several years has exceeded the initial estimate made in May, following discussions with US pharmaceutical company Terrain Pharmaceuticals regarding a sales partnership.52d ago

Similar companies

MUROMACHI CHEMICALS INC.4885.T Kubota Pharmaceutical Holdings Co.,Ltd.4596.T RIBOMIC Inc.4591.T Modalis Therapeutics Corporation4883.T SymBio Pharmaceuticals Limited4582.T Kringle Pharma,Inc.4884.T Find similar companies →

Latest newsMore news →

Medrx announced that its lidocaine tape formulation's US sales contract is expected in August, and launch in the fourth quarter.51d ago MedRx Co. announced that the expected sales volume of its lidocaine tape product Bondlido for the next several years has exceeded the initial estimate made in May, following discussions with US pharmaceutical company Terrain Pharmaceuticals regarding a sales partnership.52d ago